Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864435/0/en/Lipella-Pharmaceuticals-Expands-its-Advisory-Board-to-Include-Oncology-Expertise.html
https://www.globenewswire.com/news-release/2024/04/05/2858476/0/en/Lipella-Pharmaceuticals-to-Publish-Abstract-Detailing-Compelling-Preclinical-Support-for-New-Product-Candidate-at-ASCO-2024.html
https://www.globenewswire.com/news-release/2024/04/03/2856846/0/en/Lipella-Pharmaceuticals-Announces-FDA-Type-C-Meeting-for-LP-10-for-Hemorrhagic-Cystitis.html
https://www.globenewswire.com//news-release/2024/03/05/2840362/0/en/Lipella-Pharmaceuticals-Announces-FDA-Clearance-of-IND-for-LP-410-for-Oral-Graft-Versus-Host-Disease-Advancing-Clinical-Pipeline.html
https://www.globenewswire.com//news-release/2024/02/20/2831817/0/en/Lipella-Pharmaceuticals-to-Present-at-PropThink-Digital-Investor-Conference.html
https://www.globenewswire.com//news-release/2023/12/20/2799209/0/en/Lipella-Pharmaceuticals-Marks-Successful-First-Year-with-Strategic-Progress-and-Key-Milestones-Accomplished.html
https://www.prnewswire.com/news-releases/fda-grants-orphan-designation-for-lipellas-lp-310-drug-candidate-for-oral-graft-versus-host-disease-301984199.html
https://www.prnewswire.com/news-releases/lipella-pharmaceuticals-announces-closing-of-2-million-private-placement-priced-at-the-market-under-nasdaq-rules-301967813.html
https://www.prnewswire.com/news-releases/lipella-pharmaceuticals-announces-fda-clearance-of-ind-for-lp-310-for-oral-lichen-planus-301962718.html